Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer. Dr. Anjana Pillai explains, in an interview with ...

Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered unattainable. Dr. Augusto Villanueva Rodriguez, medical director of the Liver ...

Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma (HCC), but real-world outcomes remain heavily constrained by liver function ...

Do you sometimes feel constantly tired, no matter how much rest you get? Or experience a lingering, mild pain on the upper right side of your abdomen? You may even notice a faint yellow tinge in your ...

A woman diagnosed with stage 4 colorectal cancer is now cancer-free after a liver transplant from a lifelong friend, ...

For decades, we’ve fought cancer with the “Big Three”: surgery, chemo, and radiation. It’s often been a brutal trade-off — to ...

Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths worldwide, is extremely challenging to treat. However, the future of HCC ...

A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the risks climb toward cancer, heart attack, stroke, and even transplant. Now, ...

Tumour burden and local treatment access determine colorectal cancer outcomes rather than timing of liver metastases ...

Cirrhosis is the result of long-term liver injury where healthy tissue is replaced with scar tissue (fibrosis). Common causes of cirrhosis include alcohol use disorder (AUD), nonalcoholic fatty liver ...

Add Yahoo as a preferred source to see more of our stories on Google. A Cell Metabolism study reports that EVT0185 reduced scarring in disease models and may offer a new path for treating MASH.